Literature DB >> 19444253

Diabetes: Hypoglycemia-a new approach to an old problem.

Stephen N Davis.   

Abstract

Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe hypoglycemia in patients with long-standing type 2 diabetes mellitus, and hypoglycemia has also been recognized as a complication of bariatric surgery. New endocrine society guidelines on adult hypoglycemic disorders are, therefore, extremely pertinent.

Entities:  

Mesh：

Year:  2009        PMID： 19444253     DOI： 10.1038/nrendo.2009.54

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

Review 1.  Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.

Authors:  Diva D De León; Charles A Stanley
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-01

2.  Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.

Authors:  Juris J Meier; Alexandra E Butler; Ryan Galasso; Peter C Butler
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

3.  Hypoglycemic counterregulatory responses differ between men and women with type 1 diabetes.

Authors:  S N Davis; S Fowler; F Costa
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

4.  Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.

Authors:  Geoffrey J Service; Geoffrey B Thompson; F John Service; James C Andrews; Maria L Collazo-Clavell; Ricardo V Lloyd
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

5.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.

Authors:  A B Goldfine; E C Mun; E Devine; R Bernier; M Baz-Hecht; D B Jones; B E Schneider; J J Holst; M E Patti
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

Review 6.  Mitochondrial fatty-acid oxidation disorders.

Authors:  Michelle Kompare; William B Rizzo
Journal:  Semin Pediatr Neurol       Date:  2008-09       Impact factor: 1.636

7.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

8.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

Authors:  John B Dixon; Paul E O'Brien; Julie Playfair; Leon Chapman; Linda M Schachter; Stewart Skinner; Joseph Proietto; Michael Bailey; Margaret Anderson
Journal:  JAMA       Date:  2008-01-23       Impact factor: 56.272

9.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

10.  Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461
  10 in total
  1 in total

1.  Context-dependent memory following recurrent hypoglycaemia in non-diabetic rats is mediated via glucocorticoid signalling in the dorsal hippocampus.

Authors:  Danielle M Osborne; Kelsey E O'Leary; Dennis P Fitzgerald; Alvin J George; Michael M Vidal; Brian M Anderson; Ewan C McNay
Journal:  Diabetologia       Date:  2016-09-29       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.